OBJECTIVE: To estimate the prevalence of Mycoplasma genitalium in Toronto, Ont; detect mutations associated with macrolide and fluoroquinolone resistance; and describe treatment outcomes. DESIGN: Prospective, cross-sectional study. SETTING: A sexual health clinic in Toronto. PARTICIPANTS: A consecutive sample of men and women attending the sexual health clinic between September 1, 2013, and December 20, 2013. INTERVENTIONS: Participants underwent testing for M genitalium, along with standard sexually transmitted infection screening. All samples that had positive results for M genitalium were tested for mutations associated with resistance to macrolides and fluoroquinolones. Mycoplasma genitalium treatment was based on resistance profile and verified with a test of cure. MAIN OUTCOME MEASURES: Positive results for M genitalium and antibiotic resistance.
OBJECTIVE: To estimate the prevalence of Mycoplasma genitalium in Toronto, Ont; detect mutations associated with macrolide and fluoroquinolone resistance; and describe treatment outcomes. DESIGN: Prospective, cross-sectional study. SETTING: A sexual health clinic in Toronto. PARTICIPANTS: A consecutive sample of men and women attending the sexual health clinic between September 1, 2013, and December 20, 2013. INTERVENTIONS:Participants underwent testing for M genitalium, along with standard sexually transmitted infection screening. All samples that had positive results for M genitalium were tested for mutations associated with resistance to macrolides and fluoroquinolones. Mycoplasma genitalium treatment was based on resistance profile and verified with a test of cure. MAIN OUTCOME MEASURES: Positive results for M genitalium and antibiotic resistance.
Authors: Andreas Edberg; Margaretha Jurstrand; Eva Johansson; Elisabeth Wikander; Anna Höög; Thomas Ahlqvist; Lars Falk; Jørgen Skov Jensen; Hans Fredlund Journal: J Med Microbiol Date: 2008-03 Impact factor: 2.472
Authors: Mohammad Hossein Ahmadi; Akbar Mirsalehian; Mohammad Ali Sadighi Gilani; Abbas Bahador; Malihe Talebi Journal: Infection Date: 2017-11-09 Impact factor: 3.553
Authors: Jennifer E Balkus; Lisa E Manhart; Jørgen S Jensen; Omu Anzala; Joshua Kimani; Jane Schwebke; Juma Shafi; Charles Rivers; Emanuel Kabare; R Scott McClelland Journal: Sex Transm Dis Date: 2018-08 Impact factor: 2.830
Authors: Li Xiao; Ken B Waites; Barbara Van Der Pol; Kristal J Aaron; Edward W Hook; William M Geisler Journal: Sex Transm Dis Date: 2019-01 Impact factor: 2.830
Authors: Sarah S Romano; Jørgen S Jensen; M Sylvan Lowens; Jennifer L Morgan; Laura C Chambers; Tashina S Robinson; Patricia A Totten; Olusegun O Soge; Matthew R Golden; Lisa E Manhart Journal: Clin Infect Dis Date: 2019-06-18 Impact factor: 9.079